* GNAS, which encodes the stimulatory G protein (heterotrimeric guanine nucleotide-binding protein) a subunit (Ga s ), also encodes a large variant of Ga s termed extra-large a subunit (XLa s ), and alterations in XLa s abundance or activity are implicated in various human disorders. Although XLa s , like Ga s , stimulates generation of the second messenger cyclic adenosine monophosphate (cAMP), evidence suggests that XLa s and Ga s have opposing effects in vivo. We investigated the role of XLa s in mediating signaling by parathyroid hormone (PTH), which activates a G protein-coupled receptor (GPCR) that stimulates both Ga s and Ga q/11 in renal proximal tubules to maintain phosphate and vitamin D homeostasis. At postnatal day 2 (P2), XLa s knockout (XLKO) mice exhibited hyperphosphatemia, hypocalcemia, and increased serum concentrations of PTH and 1,25-dihydroxyvitamin D. The ability of PTH to reduce serum phosphate concentrations was impaired, and the abundance of the sodium phosphate cotransporter Npt2a in renal brush border membranes was reduced in XLKO mice, whereas PTH-induced cAMP excretion in the urine was modestly increased. Basal and PTH-stimulated production of inositol 1,4,5-trisphosphate (IP 3 ), which is the second messenger produced by Ga q/11 signaling, was repressed in renal proximal tubules from XLKO mice. Crossing of XLKO mice with mice overexpressing XLa s specifically in renal proximal tubules rescued the phenotype of the XLKO mice. Overexpression of XLa s in HEK 293 cells enhanced IP 3 generation in unstimulated cells and in cells stimulated with PTH or thrombin, which acts through a G q/11 -coupled receptor. Together, our findings suggest that XLa s enhances G q/11 signaling to mediate the renal actions of PTH during early postnatal development.
INTRODUCTION
The a subunit of the stimulatory heterotrimeric guanine nucleotide-binding protein (G s ) mediates the actions of many hormones, neurotransmitters, and autocrine or paracrine factors by stimulating the generation of the second messenger cyclic adenosine monophosphate (cAMP) (1) (2) (3) . Ga s is encoded by the imprinted GNAS complex locus, mutations in which cause multiple genetic diseases with complex parent-of-origin-specific phenotypes. Furthermore, somatic mutations in GNAS that lead to constitutive Ga s activity or increased GNAS copy number are found in multiple benign and malignant tumors. In addition to Ga s , GNAS gives rise to several different gene products, including a variant of Ga s termed extra-large a subunit (XLa s ) (4) . XLa s has a distinct N-terminal domain but is otherwise identical to Ga s . Ga s is expressed biallelically in most tissues; however, paternal Ga s expression is silenced in some tissues, such as certain parts of the brain, thyroid, pituitary gland, and renal proximal tubules (5) . In contrast, the XLa s promoter is silenced on the maternal allele and activates transcription exclusively from the paternal allele (6, 7) . Thus, most inactivating and all activating GNAS mutations affect the expression and activity of XLa s when located on the paternal allele.
In mice and humans, loss of function of XLa s is implicated in intrauterine and perinatal growth retardation, as well as poor adaptation to feeding, hypoglycemia, and disrupted glucose counterregulation (8) (9) (10) (11) . Epigenetic silencing of XLa s is found in patients with a platelet abnormality characterized by the poor effectiveness of agonists that stimulate the G s -cAMP signaling pathway, whereas its overexpression is postulated to contribute to the development of chromosome 20q-amplified breast cancers (12, 13) . Loss of imprinting at the XLa s promoter in mice, which leads to increased abundance of XLa s mRNA, also leads to early postnatal hypoglycemia and lethality (14) . Despite the clear importance of this protein in multiple systems, the cellular functions of XLa s itself and relative to the functions of Ga s remain currently unclear. At the biochemical level, XLa s behaves similarly to Ga s , and it stimulates G proteincoupled receptor (GPCR)-activated generation of cAMP when it is increased in abundance (15, 16) . On the other hand, comparison of the phenotypes of XLa s knockout (XLKO) mice with those of Ga s knockout mice suggests that the two proteins play opposing roles in vivo and that XLa s has actions that are distinct from those of Ga s (9, 17) . Moreover, XLa s has several splice variants and alternative translation products (6, (18) (19) (20) (21) , which are also ablated or overexpressed upon genetic or epigenetic defects that alter XLa s expression. The relative contributions of XLa s and these other variants to physiology and disease pathogenesis have also remained largely unclear.
To examine the cellular roles of XLa s , we focused on the actions of parathyroid hormone (PTH), which acts through Ga s in the renal proximal tubule to inhibit phosphate reabsorption and to stimulate the synthesis of the bioactive form of vitamin D (22) . PTH also uses the G q/11 signaling pathway to inhibit phosphate reabsorption in the proximal tubule, thus stimulating phospholipase Cb (PLC-b) and thereby generating the second messengers inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG), which is followed by the activation of certain protein kinase C (PKC) isozymes (23) . Overexpression studies have also shown that PTH acts through XLa s to stimulate cAMP generation (24) . Because XLa s is found in the kidney (16, 24, 25) , we investigated whether this imprinted GNAS product mediated the actions of PTH in vivo and whether its effects occurred through cAMP signaling. Our investigations showed that the loss of XLa s in the renal proximal tubule disrupted PTH-mediated phosphate handling during early postnatal development and, instead of reducing the generation of cAMP, it led to decreased G q/11 signaling. Our additional studies revealed that XLa s promoted basal and agonist-stimulated G q/11 signaling in transfected cells and in transgenic mice. Thus, XLa s mediates the proximal tubular actions of PTH and serves as a G protein a-subunit for both G s -and G q/11 -dependent signaling.
RESULTS
XLa s is located in renal proximal tubule cells during the early postnatal development of mice XLa s protein is found in whole mouse kidneys in readily detectable amounts at postnatal day 2 (P2) but not P6 (25) . Through immunostaining with an XLa s -specific antiserum, we showed that XLa s protein was located in the renal proximal tubules of P2 wild-type mice and, albeit less abundantly, in distal tubules, whereas no immunostaining was detected in other parts of the kidney (Fig. 1, A and B and fig. S1A ). XLa s protein was undetectable in samples from mice in which the paternal XLa s allele was disrupted (XLKO mice) (Fig. 1, A and B, and fig. S1A ). Loss of detectable XLa s protein upon ablation of the paternal allele alone is consistent with the exclusively paternal expression of this GNAS product, as described previously (6). Because XLa s mRNA abundance was greater at P2 than at later times (fig. S1B), we focused our efforts on determining the role of XLa s at P2. Histological analysis detected no obvious defects in tubule structures in P2 XLKO mice, although the kidneys from these mice were smaller compared to those from their wild-type littermates, consistent with the overall smaller size of the XLKO pups ( fig. S1C) (9) . Nevertheless, the abundance of mRNA for Kid1, which encodes a renal transcription factor whose mRNA accumulates in the course of postnatal renal development, was decreased by about 50% in whole kidneys from P2 XLKO mice compared to that in kidneys from wild-type mice, which suggests that there was a delay in proximal tubule development ( fig. S1D ).
XLKO mice exhibit hyperphosphatemia and hypocalcemia together with increased serum PTH
At the renal proximal tubule, PTH inhibits the reabsorption of inorganic phosphate from the glomerular filtrate and stimulates the synthesis of the active vitamin D metabolite 1,25 dihydroxyvitamin D [1, 25(OH) 2 D], which increases calcium absorption in the small intestine. P2 XLKO pups showed substantially increased concentrations of serum phosphate (hyperphosphatemia), decreased concentrations of serum calcium (hypocalcemia), as well as increased concentrations of serum PTH compared to wild-type mice (Table 1) . However, the concentration of 1,25(OH) 2 D in the serum was also markedly increased, whereas the serum concentration of fibroblast growth factor 23 (FGF23), another phosphaturic hormone that suppresses 1,25(OH) 2 D synthesis in the proximal tubule (26) , was substantially reduced in abundance in P2 XLKO pups (Table 1) .
We then examined the abundance of mRNA for renal 25-hydroxyvitamin D 1a-hydroxylase (Cyp27b1), which synthesizes 1,25(OH) 2 D, as well as that of 25-hydroxyvitamin D 24-hydroxylase (Cyp24a1), which metabolizes 1,25(OH) 2 D. The abundance of Cyp27b1 mRNA was increased more than fivefold in P2 XLKO kidneys compared to that in P2 wild-type kidneys ( Fig. 2A) , whereas that of Cyp24a1 mRNA was moderately increased in P2 XLKO kidneys (Fig. 2B) , suggesting that the increased 1,25(OH) 2 D abundance resulted from induced expression of Cyp27b1. We then examined the type II sodium-dependent phosphate cotransporter Npt2a in the renal brush border membrane because of its critical role in the reabsorption of phosphate, and we found that the abundance of its protein in P2 XLKO mice was markedly increased compared to those in P2 wild-type mice (Fig. 2 , C PTH stimulates the expression of Cyp27b1 by acting on its promoter region (27) . As expected, 2 hours after they were injected subcutaneously with PTH (50 nmol/kg), wild-type mice exhibited a 10-fold increase in the abundance of Cyp27b1 mRNA in their kidneys compared to that in the kidneys of wild-type mice injected with vehicle (Fig. 3A) . In contrast, the abundance of Cyp27b1 mRNA was increased by only 1.42-fold in XLKO mice injected with PTH compared to that in vehicle-treated XLKO mice (Fig. 3A) . Note that the XLKO pups had much higher basal Cyp27b1 expression than wild-type pups (Fig. 3A) . PTH stimulates renal phosphate excretion by decreasing the abundance of Npt2a protein in renal brush border membranes and thus leads to hypophosphatemia (28) . After they were injected with PTH, P2 wild-type mice had statistically significantly reduced serum phosphate concentrations compared to those in vehicle-treated wild-type mice, whereas the serum phosphate concentration of PTH-treated XLKO mice was not substantially reduced compared to that in vehicle-treated XLKO mice (Fig. 3B ). Similarly, divergent effects of PTH on renal Npt2a abundance in wild-type and XLKO mice were also observed (Fig. 3, C and D) . Fifteen minutes after they were injected with PTH, wild-type mice showed an 80% decrease in the abundance of Npt2a in the renal brush border membrane than did vehicle-treated wild-type mice, whereas the effect of PTH on reducing Npt2a abundance in the renal brush border membranes of XLKO mice was less substantial (Fig. 3 , C to E). These results suggest that the proximal tubular actions of PTH in XLKO mice were blunted compared to those in wild-type mice.
To characterize the role of XLa s in mediating the actions of PTH, we tested whether XLKO exhibited a reduction in the PTH-induced secretion of cAMP from the kidney into the urine, a test that is used to assess the proximal tubular action of PTH and to establish a diagnosis of PTH resistance in patients (29) . The basal concentrations of urinary cAMP in P2 wild-type and XLKO mice were similar 15 min after they received subcutaneous injections of vehicle (Fig. 4A) . Injection with PTH led to increased concentrations of urinary cAMP in wild-type and XLKO pups; however, the concentrations were statistically significantly greater in the Data are means ± SEM of six or seven mice from each group. *P < 0.05, **P < 0.01. (E) Extent of the PTH-induced reduction in Npt2a abundance in the indicated WT and XLKO mice relative to that in vehicle-treated mice. Data are means ± SEM of three independent experiments. *P < 0.05. XLKO mice than in their wild-type littermates (Fig. 4A) . We then measured Ga s mRNA abundance in whole kidneys and found a moderate, but statistically significant, increase in those of P2 XLKO mice compared to those of wild-type mice (Fig. 4B ). Western blotting analysis revealed a threefold increase in the abundance of Ga s protein in the brush border membranes of XLKO mice compared to that in the brush border membranes of wild-type mice (Fig. 4, C and D) . Immunostaining of kidney sections with antiserum directed against the unique N-terminal portion of Ga s (and that cannot recognize XLa s ) was also suggestive of increased amounts of Ga s protein in the kidneys of XLKO mice ( fig. S3 ).
XLKO pups show repressed G q/11 signaling
Because the PTH-stimulated generation of cAMP was not impaired in P2 XLKO mice, we examined the G q/11 signaling pathway, which can be activated by PTH and contributes to the regulation of serum phosphate concentrations (23, 30, 31) . In proximal tubule-enriched renal cortices isolated from P2 XLKO kidneys, we found that the intracellular amount of the IP 3 metabolite inositol monophosphate (IP 1 ), which reflects IP 3 generation, was substantially reduced under basal conditions, as well as upon stimulation with PTH ( Fig. 5A ). Western blotting analysis showed that the abundances of PKCd, PKCa, and PKCz, but not PKCbII or PKCq, were decreased in the cytosolic fractions of XLKO samples compared to those in cytosolic fractions of samples from wild-type mice ( Fig. 5B and fig. S4 , A and B). PKCd abundance was also markedly decreased in the membrane fractions of XLKO samples, whereas the abundances of PKCa and PKCz were only slightly reduced (Fig. 5, B to E) . Moreover, the abundances of PKCd, PKCa, and PKCz after PTH treatment were substantially decreased in both the cytosolic and membrane fractions of XLKO samples compared to those of wild-type samples (Fig. 5, B to E) . Western blotting analysis indicated no reduction in the abundance of phosphorylated extracellular signalregulated kinase 1 (ERK1) and ERK2 in the proximal tubules from XLKO mice either under basal conditions or after stimulation with PTH ( fig. S4 , C and D), whereas the amounts of phosphorylated PKA targets were slightly increased in membrane fractions after stimulation with PTH ( Fig. 5B and  fig. S4E ).
Hyperphosphatemia and reduced G q/11 signaling in XLKO mice are rescued by overexpression of XLa s specifically in proximal tubules Knockout of the gene encoding XLa s in XLKO mice ablates not only XLa s but also its variants in all tissues (9) . To determine whether the proximal tubule-specific overexpression of XLa s could rescue the hyperphosphatemia phenotype of P2 XLKO mice, we crossed XLKO mice to transgenic mice in which XLa s expression was targeted to the renal proximal tubule with the Fig. 4 . Ga s abundance in proximal tubules and PTH-induced concentrations of urinary cAMP are increased in P2 XLKO mice. (A) P2 XLKO and WT littermate mice were injected subcutaneously with vehicle or PTH (50 nmol/kg). Fifteen minutes later, the concentrations of cAMP in the urine of the mice were determined and expressed relative to the amounts of urinary creatinine. Data are means ± SEM of six to nine mice per group from three independent experiments. *P < 0.05; ***P < 0.001. (B) Whole kidneys from P2 WT and XLKO mice were subjected to qRT-PCR analysis to determine the relative amounts of Ga s mRNA. Data are means ± SEM of 12 mice per group from four independent experiments. **P < 0.01. (C) Renal brush border membranes isolated from WT and XLKO mice were subjected to Western blotting analysis with an antibody that recognizes both Ga s and XLa s , as indicated. Villin was used as a loading control. (D) Densitometric analysis of the relative abundance of Ga s protein normalized to that of villin in WT and XLKO mice from the experiments represented in (C). Data are means ± SEM of four mice from each group. **P < 0.01. Proximal tubule-enriched cortices isolated from P2 WT or XLKO mice were left untreated or were treated with PTH for 30 min. Samples were then subjected to fractionation, and the indicated membrane and cytosolic fractions were subjected to Western blotting analysis with antibodies specific for the indicated proteins. Western blots are representative of three independent experiments that combined samples from four to five pups of each genotype. (C to E) Densitometric analysis of the relative abundances of PKCd (C), PKCa (D), and PKCz (E) proteins in the membrane and cytosolic fractions of the indicated mice from the experiments represented in (B). Data are means ± SEM of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
promoter of the gene encoding the type I rat g-glutamyltranspeptidase (rptXLa s mice) (25) . We found that this promoter was active at the P2 stage and that the abundance of XLa s mRNA in rptXLa s mice was 12-fold higher than that in wild-type littermates (Fig. 6A) . Whereas the XLKO offspring from these matings showed hyperphosphatemia, rptXLa s offspring tended to have reduced concentrations of serum phosphate (Fig. 6B) . Serum phosphate concentrations were statistically significantly lower in the XLKO:rptXLa s offspring than in the XLKO offspring, and these concentrations were comparable to those in wild-type littermates (Fig. 6B) . In addition, the increase in Cyp27b1 expression observed in XLKO mice was effectively reversed by transgenic overexpression of XLa s (Fig. 6C) , although the expression of Cyp24a1 was still increased in the XLKO:rptXLa s mice (Fig. 6D) . The reduced abundance of Kid1 mRNA in XLKO mice was also fully rescued by overexpression of XLa s in proximal tubules (Fig. 6E) . Western blotting analysis revealed that the reduction in the abundances of PKCd, PKCa, and PKCz in the proximal tubules of XLKO mice was also rescued by the proximal tubule-specific overexpression of XLa s (Fig. 6, F to I ). In particular, overexpression of XLa s in the proximal tubule substantially increased the membrane abundance of PKCd, which was evident in both rptXLa s and XLKO:rptXLa s pups (Fig. 6, F and G) . Basal and PTH-stimulated concentrations of IP 1 were statistically significantly increased in proximal tubule-enriched cortices isolated from P2 rptXLa s mice compared to those in similar cortices isolated from wild-type littermates (Fig. 7A) . Concordant with these results, transient transfection of human embryonic kidney (HEK) 293 cells stably expressing the PTH receptor with increasing amounts of plasmid encoding XLa s resulted in a dose-dependent increase in basal IP 1 concentrations (Fig. 7B) . Moreover, cells transfected with either control plasmid or plasmid encoding XLa s responded to PTH, but the overexpression of XLa s substantially enhanced the generation of IP 1 in response to different concentrations of PTH (Fig. 7C) . Furthermore, overexpression of XLa s in these cells also enhanced the amount of IP 1 generated in response to thrombin, another agonist that acts through its own endogenous G q -coupled receptor (Fig. 7D ). In addition, we examined a guanosine triphosphatase (GTPase)-deficient mutant of XLa s (XLa s -R543H), which shows constitutive activity with respect to cAMP generation (24) . As expected, HEK 293 cells transiently expressing this mutant XLa s displayed increased basal cAMP generation compared to those cells expressing wild-type XLa s (Fig. 7E) . Similarly, basal IP 1 concentrations were substantially greater in HEK 293 cells expressing XLa s -R543H than in those expressing wild-type XLa s (Fig. 7F) .
To determine whether XLa s could mimic the actions of Ga q/11 proteins, we expressed XLa s in HEK 293 cells in which Ga q and Ga 11 were both ablated through the use of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 system (CRISPR-associated). Thrombin stimulated a 2.55-fold increase in IP 1 generation in native HEK 293 cells compared to that in unstimulated cells (Fig. 7G) , whereas it failed to stimulate IP 1 generation in Ga q/11 -deficient HEK 293 cells that were transfected with control plasmid (Fig. 7H) . Transient transfection of the Ga q/11 -deficient HEK 293 cells with plasmid encoding either Ga q or Ga 11 led to an increase in basal IP 1 concentrations and rescued the thrombin-stimulated generation of IP 1 (Fig. 7H) . In Ga q/11 -deficient HEK 293 cells transfected with plasmid encoding XLa s , the basal IP 1 concentration was 3.39-fold greater than that in cells transfected with the control plasmid, and thrombin stimulated a 1.81-fold increase in IP 1 abundance compared to that in unstimulated Ga q/11 -deficient cells expressing XLa s (Fig. 7H) .
DISCUSSION
We investigated the role of XLa s , a variant of Ga s , by focusing on the action of PTH, and our data suggest that XLa s is essential for the PTH-mediated regulation of phosphate handling in the renal proximal tubule during early postnatal development. Whereas this role of XLa s appears to be similar to that of Ga s in the same context, we found that the ablation of XLa s in mice repressed G q/11 -mediated signaling rather than G s -mediated signaling. Our additional results suggest that XLa s promotes basal and agonist-stimulated signaling that is typically downstream of G q/11 proteins.
By stimulating at least two signaling pathways, which are mediated by G s and G q/11 proteins, PTH inhibits renal phosphate reabsorption by decreasing the abundance of Npt2a protein. The hyperphosphatemia in XLKO mice is thus consistent with an increase in the amount of Npt2a at steady state and the blunted PTH-induced reduction in Npt2a abundance. FGF23 also decreases the abundance of Npt2a (32) , and therefore, the increased Npt2a abundance would be consistent with the reduction in the amount of FGF23 in XLKO mice. However, a role for reduced FGF23 in P2 XLKO mice is unlikely because complete ablation of FGF23 in mice does not lead to alterations in serum phosphate and calcium concentrations until after P6 (33, 34) . PTH also increases the synthesis of 1,25(OH) 2 D by inducing the expression of Cyp27b1, but this effect depends largely on G s -dependent signaling (27, 35) . Because the serum PTH concentration was increased in XLKO pups compared to that in wild-type pups, and because this was concurrent with markedly increased amounts of renal Cyp27b1 mRNA and 1,25(OH) 2 D, it is possible that the action of PTH on Cyp27b1 expression is somewhat preserved in the absence of XLa s . In support of this possibility was the tendency of renal Cyp27b1 mRNA abundance to increase even more than the already enhanced amounts in response to PTH in XLKO pups (Fig. 4A) . A reduction in the amount of serum FGF23 is unlikely to account for the increased amount of 1,25(OH) 2 D in P2 XLKO pups because FGF23-deficient mice do not display increased amounts of 1,25(OH) 2 D until after P10 (33). 1,25(OH) 2 D stimulates the expression of Cyp24a1, which would thus explain the increased renal abundance of Cyp24a1 mRNA in XLKO pups.
The hypocalcemia in XLKO pups is more difficult to explain, given their increased amounts of 1,25(OH) 2 D, which normally enhances Ca 2+ absorption in the gut. In newborns, however, deficiency in 1,25(OH) 2 D or the loss of its receptor does not lead to hypocalcemia, which suggests that this hormone is not essential for regulating serum Ca 2+ concentrations during early postnatal life (36) . It is possible that the reduced serum concentration of Ca 2+ in XLKO pups is secondary to hyperphosphatemia or reflects the poor Data are means ± SEM of 12 samples per group from four independent experiments. **P < 0.01, ***P < 0.001.
feeding of the XLKO pups (9) . In addition, PTH enhances the reabsorption of Ca 2+ in the renal distal tubule (22) . Because we detected XLa s protein in this part of the nephron, PTH-induced reabsorption of Ca 2+ may be impaired in P2 XLKO mice, thus contributing to the hypocalcemia despite the presence of increased amounts of PTH in the serum of these mice.
The PTH resistance in XLKO pups was observed in the presence of intact, and modestly increased, Ga s abundance and an enhanced PTH-stimulated cAMP response. In contrast, basal and PTH-stimulated IP 3 signaling and the abundances of certain PKC isoforms were repressed. In addition, overexpression of XLa s in the proximal tubules of XLKO pups rescued both the hyperphosphatemia and the diminished generation of IP 1 . It thus appears that the impaired responsiveness of Npt2a to PTH in the proximal tubules of XLKO mice, and the resultant changes in serum biochemistries of XLKO pups, is at least partly a result of the impaired activation of IP 3 -DAG signaling. Together with the results of our cell culture experiments, these findings suggest that XLa s serves as a Ga q/11 -like signaling protein and that it mediates the PTH-induced inhibition of phosphate reabsorption from the glomerular filtrate. Previous studies showed that the G q/11 signaling pathway and the activation of PKC play crucial roles in the PTH-stimulated internalization of Npt2a and regulation of phosphate homeostasis (37) (38) (39) . Our findings confirm the importance of this signaling pathway to the renal actions of PTH, and they identify XLa s as an indispensable mediator of those actions during early postnatal development. Given that XLKO mice that survive to weaning show normal concentrations of phosphate, Ca
2+
, and PTH in the serum (14) , the phenotypes of XLKO pups are similar to the clinical findings of patients with transient neonatal pseudohypoparathyroidism, who show hypocalcemia, hyperphosphatemia, and increased serum PTH concentrations during early postnatal life (40, 41) . Whether these patients have mutations in exon 1 of their paternal GNAS XLa s or in genes encoding the signaling partners of XLa s should be investigated.
Despite having increased serum PTH concentrations and Ga s protein abundance in renal brush border membranes, XLKO mice had baseline urinary cAMP concentrations that were indistinguishable from those of wild-type mice. This finding may reflect a lack of sensitivity of our cAMP measurement assay. Alternatively, XLKO pups may have developed adaptive changes to prevent increases in urinary cAMP concentration at steady state, such as desensitization of the mechanism responsible for the efflux of cAMP into the urine. The quantities of phosphorylated PKA substrates in the proximal tubules of unstimulated XLKO and wild-type mice were similar, suggesting that other adaptive changes may have occurred, such as in the relative amounts of cAMP phosphodiesterases (Fig. 5 and fig. S4E ). In contrast, phosphorylated PKA substrates were substantially more abundant in the proximal tubule membranes of PTH-stimulated XLKO mice than in those of PTH-stimulated wild-type mice. It is possible that the exchange protein activated by cAMP (Epac) is also activated more robustly in the proximal tubules of XLKO mice than in the proximal tubules of wild-type mice, particularly after receptor stimulation. Epac plays important roles in proximal tubules through its stimulation of ERK1/2 signaling (42, 43) ; however, the abundance of phosphorylated ERK1/2 was not altered in the proximal tubules of XLKO mice ( fig. S4, C and D) . Moreover, a study suggests that Epac activation is not involved in renal phosphate handling or the regulation of Npt2a (44), arguing against the possibility that enhanced Epac activity contributes to the hyperphosphatemia observed in XLKO pups.
Consistent with the marked identity between the amino acid sequences of XLa s and Ga s , in vitro overexpression experiments indicate that XLa s stimulates both basal and receptor-activated generation of cAMP (24, 25) ; however, no cAMP-independent cellular functions have hitherto been assigned to XLa s . Our study suggests that even though it is a Ga s -like protein, XLa s promotes the G q/11 signaling pathway in vivo. Thus, the GNAS complex locus presents an interesting paradigm in which a single gene encodes partially identical Ga subunits that stimulate two different G proteinmediated pathways. Unlike in the regulation of PTH-mediated phosphate handling, the G s -and G q/11 -dependent signaling pathways mediate opposing responses in many tissues, such as platelets and airway smooth muscles (45, 46) . Consistent with these actions, previous studies have indicated that Ga s and XLa s have opposing roles in vivo (17, 47) .
The effect of XLa s on G q/11 signaling and PKC isoform abundance could be developmental, but our experiments with transiently transfected cells suggest that XLa s directly enhances the activation of PLC-b. Moreover, results from experiments with the GTPase-deficient XLa s mutant, which is analogous to the Ga s mutant R201H that is found in multiple benign and malignant tumors (3), indicate that this action of XLa s is also limited by its intrinsic GTPase activity. In addition, our findings obtained from experiments with Ga q/11 -deficient cells suggest that XLa s stimulates IP 3 generation at least partly by mimicking the actions of Ga q and Ga 11 . It could be argued that XLa s promotes the G q/11 signaling pathway by increasing the abundance of cAMP, because cAMP signaling in some cells can stimulate certain PLC isozymes (48) . In overexpression experiments, a similar mechanism could perhaps be involved in the XLa s -mediated generation of IP 3 , particularly under basal conditions; however, thrombin receptors do not couple to G s proteins (49) , and therefore, thrombin-induced IP 3 generation in XLa s -expressing, Ga q/11 -deficient cells is unlikely to be secondary to cAMP generation. Our findings from in vivo experiments also argue against the involvement of a cAMP-dependent mechanism, because XLKO pups showed increased PTH-stimulated generation of cAMP in the proximal tubule despite having diminished G q/11 -mediated signaling.
PKCs are divided into three subfamilies: conventional, novel, and atypical. Conventional PKCs, such as PKCa, and novel PKCs, such as PKCd, require DAG for their activation and are thus downstream of G q/11 signaling (50). The inhibited generation of IP 3 , as well as the decreased abundances of PKCd and PKCa, in the proximal tubules of P2 XLKO mice suggests that XLa s plays a stimulatory role in G q/11 signaling. On the other hand, PKCz, which is an atypical PKC that does not require DAG or Ca 2+ for activation (51) , was also reduced in abundance in samples from XLKO mice, suggesting that XLa s might also regulate the abundance of atypical PKCs through an asyet-undefined mechanism. PTH stimulates PKC activation in a PLCindependent manner (52), which might possibly be mediated by XLa s .
That loss of XLa s increased the PTH-stimulated generation of cAMP is consistent with data from experiments with brown adipose tissue (BAT) from XLKO mice, in which basal and isoproterenol-stimulated cAMP generation were enhanced compared to those in BAT from wild-type mice (9) . Our results suggest that the increased production of cAMP in the proximal tubules of XLKO mice is at least partly a result of increased Ga s abundance. It is tempting to speculate that the changes in Ga s abundance reflect a physiological response to help counteract the hyperphosphatemia. The change in Ga s abundance in proximal tubules from XLKO mice may also result from the loss of a potential regulatory mechanism involving an interaction in cis between the paternal XLa s transcript and the downstream Ga s promoter, because a similar mechanism involving another paternally expressed upstream GNAS transcript (A/B) and the Ga s promoter has been proposed (53) .
GNAS is a highly complex locus, and XLa s itself has multiple variants and alternative translational products (6, (18) (19) (20) (21) . The XLKO mice have a deletion in extra-large exon 1, thus ablating all of these variants (9) . Thus, the PTH-resistant phenotype of XLKO pups could reflect a deficiency in one or more of these proteins. However, the phenotype was rescued by overexpressing XLa s in the proximal tubule, and it is therefore likely that the phenotype reflects a specific deficiency in XLa s , rather than its other variants, in this tissue. Note that the XLKO:rptXLa s pups appeared grossly indistinguishable from their XLKO littermates and showed a similar degree of early postnatal lethality, indicating that other XLa s variants could be responsible for these other defects.
In summary, our study revealed a hitherto unknown function of the large Ga s variant XLa s , demonstrating that this imprinted protein can enhance the G q/11 signaling pathway. Our studies with XLa s -deficient mice also suggest that XLa s is required for the action of PTH in the proximal tubules of early postnatal mice with respect to phosphate handling. These findings have broad implications regarding the pathogenesis of human diseases caused by GNAS mutations or copy number variations.
MATERIALS AND METHODS

Mice
XLKO mice and rptXLa s mice (9, 25) were maintained in a CD1 genetic background. All the animal experiments were conducted in accordance with the accepted standards of the Institutional Animal Care and Use Committee, and the studies were approved by the Massachusetts General Hospital Subcommittee on Research Animal Care.
Expression plasmids
Construction of plasmids encoding XLa s and the GTPase-deficient XLa s mutant XLa s -R543H was described previously (20, 24) . Plasmids encoding Ga q and Ga 11 were obtained from www.cDNA.org.
cDNA synthesis and qRT-PCR analysis
Total RNA isolated from the kidneys of P2 wild-type, XLKO, rptXLa s , and XLKO:rptXLa s mice was prepared with the RNeasy Plus Mini Kit (Qiagen), and cDNAwas synthesized with the ProtoScript II First Strand cDNA Synthesis Kit (New England Biolabs) as previously described (54) . qRT-PCR analysis was performed with specific primers (table S1) and FastStart Universal SYBR Green Master (Roche) with Actb (b-actin) as a reference gene.
Immunofluorescence microscopy
Kidneys were isolated from P2 XLKO and wild-type littermates, fixed, and serially sectioned at 5 mm. Sections were incubated with polyclonal antiserum against mouse XLa s (25) at a 1:500 dilution, antibody specific for the N-terminal region of Ga s encoded by exon 1 (1:500) (a gift of S. Mollner, Germany) (4), or antibody against calbindin D-28K (Sigma) at 4°C overnight. Sections were then incubated with Alexa Fluor 568-conjugated donkey anti-rabbit antibody and Alexa Fluor 488-conjugated phalloidin or with Alexa Fluor 488-conjugated goat anti-mouse antibody (Life Technologies) at room temperature for 1 hour (24) . Immunoreactivity was visualized and analyzed with a Zeiss LSM 510 confocal microscope and Zeiss Zen software.
Measurement of serum biochemistries
Blood samples for the analysis of serum concentrations of phosphate, Ca 2+ , PTH, and 1,25(OH) 2 D were obtained from the carotid artery and were processed as described previously (25) . Serum FGF23 concentrations were measured with the Mouse/Rat FGF-23 (C-Term) ELISA Kit (Immutopics). To determine the effect of PTH on cAMP generation in vivo, urine was collected 15 min after mice were injected subcutaneously with vehicle or PTH(1-34) (50 nmol/kg), and the concentration of cAMP was quantified as described previously (14) . The PTH-induced reduction in the concentration of serum phosphate was measured 2 hours after mice were injected with PTH(1-34) or vehicle as previously described (25) .
Isolation and Western blotting analysis of renal brush border membranes
Brush border membrane portions were isolated from the kidneys of P2 mice as described previously (55) with minor modifications. Isolated brush border membrane proteins were lysed in a tris-buffered solution containing 150 mM NaCl and 1% Triton and a protease inhibitor cocktail (Roche). Measurement of protein concentrations in the samples and Western blotting analysis with antibodies specific for Npt2a, Npt2c (56), and Ga s (Millipore) were performed as described previously (25) .
Isolation of proximal tubule-enriched cortices and IP 1 assays
Proximal tubule-enriched renal cortices were prepared by collagenase digestion of P2 mouse kidneys and isolation on a Percoll gradient as described previously (57) . Proximal tubules from P2 wild-type, XLKO, or rptXLa s mice were treated with different concentrations of PTH 
cAMP signaling assays
Signaling through the cAMP and PKA pathway was assessed in experiments with HEK 293 cells stably transfected with the GloSensor cAMP reporter plasmid and with plasmid encoding PTHR and then transiently transfected with plasmids encoding XLa s or XLa s -R543H. For assays, confluent cells in 96-well plates were treated with luciferin and 2 mM 3-isobutyl-1-methylxanthine for 30 min before luminescence was measured as previously described (58) .
Cell fractionation and analysis of PKC isoforms
Proximal tubule-enriched renal cortices were subjected to cell fractionation by ultracentrifuge to separate cytosolic and membrane fractions (59) . Protein lysates were resolved by 10% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes (Bio-Rad). Western blots were then incubated with antibodies directed against specific PKC isoforms, phosphorylated substrates of PKA, and phosphorylated ERK1/2 (Cell Signaling). Antibodies against actin (Santa Cruz Biotechnology) and the Na,K-ATPase (Cell Signaling) were used to identify cytosolic and membrane fractions. Densitometric analysis of Western blots was performed with ImageJ software.
Statistical analysis
The means ± SEM of multiple independent measurements were calculated. To determine statistical significance, Leven's F test was first performed to assess equality of variances. If variances were equal, the Student's t test (two-tailed) assuming equal variance was used for comparing two means, whereas one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test was used for comparing three or more groups. Welch's t test (two-tailed) was used for comparisons between two means with unequal variances. The same test was used for multiple comparisons involving groups with unequal variances, followed by Bonferroni correction (that is, P values were multiplied by the number of comparisons). Statistical significance is represented as follows: *P < 0.05, **P < 0.01, ***P < 0.001.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/8/391/ra84/DC1 Fig. S1 . XLa s is located in the kidney at early postnatal stages, and XLKO mice do not have defects in renal structure. Table. S1. Sequences of the primer pairs used in qRT-PCR assays.
